Literature DB >> 2197946

The epidemiology of cardiovascular disease in postmenopausal women.

T L Bush1.   

Abstract

This manuscript has described the principal modifiable risk factors for the major killer of postmenopausal women. Clearly women who smoke should be convinced to quit, and those who have hypertension and hypercholesterolemia should be encouraged initially to adopt hygienic interventions (that is weight reduction and moderate exercise) to lower their blood pressures and cholesterol levels. Further, given the magnitude of the risk reduction in CVD seen in estrogen users, estrogen use ought to be considered as a preventive therapy for postmenopausal women, but particularly for those who are at high risk of cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2197946     DOI: 10.1111/j.1749-6632.1990.tb30338.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  13 in total

Review 1.  Evidence-based management of dyslipidemias in women.

Authors:  John C LaRosa
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

2.  ALDH2 and CYP2E1 genotypes, urinary acetaldehyde excretion and the health consequences in moderate alcohol consumers.

Authors:  Yuichi Yamada; Tsunehiko Imai; Masao Ishizaki; Ryumon Honda
Journal:  J Hum Genet       Date:  2005-12-20       Impact factor: 3.172

3.  Oestrogen and progesterone inhibit the stimulated production of endothelin-1.

Authors:  A K Morey; M Razandi; A Pedram; R M Hu; B A Prins; E R Levin
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

Review 4.  Outcomes of lipid-lowering treatment in postmenopausal women.

Authors:  John C LaRosa
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

5.  Tibolone inhibits aortic atherosclerotic lesionformation in oophorectomized cholesterol-fed rabbits.

Authors:  Camil Castelo-Branco; Alex Sanjuán; Carles Ascaso; Marta Colodrón; Juan Enrique Blümel; Elena Casals; Jaume Ordi; Juan Antonio Vanrell
Journal:  Exp Clin Cardiol       Date:  2003

6.  Efficacy and safety of fluvastatin, a new HMG CoA reductase inhibitor, in elderly hypercholesterolaemic women.

Authors:  G Baggio; O De Candia; P L Forte; F Mello; A Andriolli; S Donazzan; G Valerio; M Milani; G Crepaldi
Journal:  Drugs       Date:  1994       Impact factor: 9.546

7.  A screening procedure detecting high-yield candidates for OGTT. The Women's Health in the Lund Area (WHILA) study: a population based study of middle-aged Swedish women.

Authors:  J Lidfeldt; C Nerbrand; G Samsioe; B Scherstén; C D Agardh
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

8.  Debate: The potential role of estrogen in the prevention of heart disease in women after menopause.

Authors:  Rebecca R Johnson; Mary E Sweeney
Journal:  Curr Control Trials Cardiovasc Med       Date:  2000

9.  Relationship between postprandial endotoxemia in nonobese postmenopausal women and diabetic nonobese postmenopausal women.

Authors:  Gaffar Sarwar Zaman; Fawzia Zaman
Journal:  J Nat Sci Biol Med       Date:  2015 Jan-Jun

10.  Effect of Nigella sativa on reproductive system in experimental menopause rat model.

Authors:  Saadat Parhizkar; Latiffah Abdul Latiff; Ali Parsa
Journal:  Avicenna J Phytomed       Date:  2016 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.